Health & Biotech
PharmAust (ASX: PAA) has changed its name to Neurizon Therapeutics - NUZ (ASX: NUZ).
Below are the previous articles from PharmAust (ASX: PAA):
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Tech, Energy weigh down ASX; Schrole up almost 200pc on acquisition deal
News
ASX Small Caps Lunch Wrap: Which European food-babies just can’t handle the heat this week?
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Health stocks flat as ACCC scrutinises Sigma and Chemist Warehouse merger
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
PharmAust’s monepantel drug could be a game-changer for MND/ALS patients, new data shows
News
ASX Small Caps Lunch Wrap: Who somehow managed to be shocked by a Madonna concert this week?
News
Top 10 at 10: Kava stock bags on sales blitz, Treasury Wines pops corks on guidance update
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX rebounds 1.6pc in May; Guzman y Gomez talks IPO fiesta
Health & Biotech
PharmAust puts experienced hands back on its rudder
Health & Biotech
ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System
Health & Biotech
‘Outstanding milestone’: FDA grants PharmAust orphan drug designation for monepantel
News
Closing Bell: Market mood swings as ASX tumbles, iron ore and lithium miners rise on China hopes
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
PharmAust plans for pivotal Phase 2/3 trial after key quarter of milestones
Health & Biotech
